BARBARA KISH: Open Payments
NPI 1902894769 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 34 payments from 13 companies in 2025. Trend: 2023 $493 · 2024 $489 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $183 |
| ABBVIE INC. | 6 | $89 |
| ViiV Healthcare Company | 3 | $73 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Organon LLC | 3 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| Cipher Pharmaceuticals US LLC | 1 | $21 |
Products named: MAVYRET, APRETUDE, AIRSUPRA, NUVARING, DOVATO, PIFELTRO, SPRAVATO, GVOKE HYPOPEN.
Industry payments across MI — which companies pay providers there.
